Sponsor

LHL Helse

Clinical research sponsor

Published trials13

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

13 shown

A Small Nudge for Better Health Through Reduced Salt Intake, Increased Vegetable Intake, and Smaller Portion SizeNCT02808910 · lead sponsor · 2016-04-01

COMPLETED

Troponin T in Chronic Obstructive Pulmonary Disease (COPD) Patients After Physical ExerciseNCT02721693 · lead sponsor · 2016-04-01

COMPLETED

The Short Physical Performance Battery in Chronic Obstructive Pulmonary Disease (COPD)NCT02314338 · lead sponsor · 2014-09-01

COMPLETED

Effect of Oxygen Supplementation During Exercise in Chronic Obstructive Pulmonary Disease PatientsNCT02108925 · lead sponsor · 2014-04-01

COMPLETED

Changes in Blood Gases, Disturbance of Breath During Sleep and Cardiovascular Co-morbidity in COPD PatientsNCT00888342 · lead sponsor · 2009-05-01

COMPLETED

Exercise Pulseoximetry for Pre-flight Evaluation of Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00896584 · lead sponsor · 2009-05-01

COMPLETED

ADL- Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00887705 · lead sponsor · 2009-05-01

COMPLETED

Sickness Absence Versus Physical, Mental, and Job-related Factors in Patients With Chronic Pulmonary DiseaseNCT01118104 · lead sponsor · 2008-01-01

COMPLETED

Writing About Disease: Effect on Rehabilitation?NCT00251420 · lead sponsor · 2005-12-01

COMPLETED

Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOTNCT00249093 · lead sponsor · 2005-10-01

COMPLETED

Pressure Dependent Tracheal Obstruction in Copd PatientsNCT01679808 · lead sponsor · 2004-08-01

COMPLETED

Diastolic Dysfunction During Conservative Lifestyle TreatmentNCT02826122 · collaborator · 2016-08-01

COMPLETED

Long-Term Integrated Telerehabilitation of COPD Patients. A Multi-Center TrialNCT02258646 · collaborator · 2014-10-01

COMPLETED

Sponsor roles

lead sponsor11

collaborator2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.